These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2644580)

  • 21. PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.
    Nuebling G; Hensler M; Paul S; Zwergal A; Crispin A; Lorenzl S
    J Neurol; 2016 Aug; 263(8):1565-74. PubMed ID: 27230855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects.
    Hohagen F; Riemann D; Spiegel R; Holzhauer M; Berger M
    Neuropsychopharmacology; 1993 Nov; 9(3):225-32. PubMed ID: 8280346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep and quantitative EEG in patients with progressive supranuclear palsy.
    Montplaisir J; Petit D; Décary A; Masson H; Bédard MA; Panisset M; Rémillard G; Gauthier S
    Neurology; 1997 Oct; 49(4):999-1003. PubMed ID: 9339679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
    Berger M; Riemann D; Höchli D; Spiegel R
    Arch Gen Psychiatry; 1989 May; 46(5):421-8. PubMed ID: 2712660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
    Kasashima S; Oda Y
    Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rest-activity rhythm disruption in progressive supranuclear palsy.
    Walsh CM; Ruoff L; Varbel J; Walker K; Grinberg LT; Boxer AL; Kramer JH; Miller BL; Neylan TC
    Sleep Med; 2016 Jun; 22():50-56. PubMed ID: 27544836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
    Nissen C; Nofzinger EA; Feige B; Waldheim B; Radosa MP; Riemann D; Berger M
    Neuropsychopharmacology; 2006 Jun; 31(6):1294-300. PubMed ID: 16192980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease.
    Nomura T; Inoue Y; Takigawa H; Nakashima K
    Parkinsonism Relat Disord; 2012 May; 18(4):394-6. PubMed ID: 22115673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
    Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN
    Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
    Burrell JR; Ballard KJ; Halliday GM; Hodges JR
    J Alzheimers Dis; 2018; 61(2):705-715. PubMed ID: 29254097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep Architecture in Progressive Supranuclear Palsy: A Video-Polysomnography Study.
    Boini SY; Mahale R; Donaparthi S; Kamble N; Holla VV; Pal PK; Kutty B; Yadav R
    Ann Indian Acad Neurol; 2022; 25(5):858-863. PubMed ID: 36560999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related disorders of sleep and motor control in the rat models of functionally distinct cholinergic neuropathology.
    Ciric J; Lazic K; Petrovic J; Kalauzi A; Saponjic J
    Behav Brain Res; 2016 Mar; 301():273-86. PubMed ID: 26756440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy for progressive supranuclear palsy: past and future.
    Cole DG; Growdon JH
    J Neural Transm Suppl; 1994; 42():283-90. PubMed ID: 7964693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons.
    Lim AS; Moro E; Lozano AM; Hamani C; Dostrovsky JO; Hutchison WD; Lang AE; Wennberg RA; Murray BJ
    Ann Neurol; 2009 Jul; 66(1):110-4. PubMed ID: 19670451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy.
    Brusa L; Ponzo V; Mastropasqua C; Picazio S; Bonnì S; Di Lorenzo F; Iani C; Stefani A; Stanzione P; Caltagirone C; Bozzali M; Koch G
    Brain Stimul; 2014; 7(1):29-35. PubMed ID: 23928103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic, Glutamatergic, and GABAergic Neurons of the Pedunculopontine Tegmental Nucleus Have Distinct Effects on Sleep/Wake Behavior in Mice.
    Kroeger D; Ferrari LL; Petit G; Mahoney CE; Fuller PM; Arrigoni E; Scammell TE
    J Neurosci; 2017 Feb; 37(5):1352-1366. PubMed ID: 28039375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of physostigmine on swallowing and oral motor functions in patients with progressive supranuclear palsy: A pilot study.
    Frattali CM; Sonies BC; Chi-Fishman G; Litvan I
    Dysphagia; 1999; 14(3):165-8. PubMed ID: 10341115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of mania with the cholinomimetic agent RS 86.
    Krieg JC; Berger M
    Br J Psychiatry; 1986 May; 148():613. PubMed ID: 3535973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.